Revok50 Is Medical Device CE Class III Certificate in The Form of Sterile Gel Intended for Intradermal Injections.

• Type: Surgical Supplies Materials
• Material: Plastic
• Ethylene Oxide Sterilization: Without Ethylene Oxide Sterilization
• Quality Guarantee Period: Two Years
• Group: Adult
• Logo Printing: With Logo Printing
• Certification:Tce Disinfection:Tneed to: Unisex
• Model No.: Soft MID Strong Implant
• Pharmaceutical Technology: Chemical Synthesis
• Disposable: 8-18 Months After Injection
• Side Effect: Some Conditions Are Not Suitable for Injection
• Usage: Dermal Injection
• Efficacy: Whitening, Wrinkle Filling, Plump Filling, etc.
• Ingredient: Chemical, Cross Linked Hyaluronic Acid Gel
• Size Type: Regular Size
• Use: Body, Breast, Neck, Nose, Foot, Hand, Face
• .Transport Package: Aseptic Packaging
• Transport Package: Carton Transport
• Specification: 1.1ml
• Trademark: ce
• Origin: Korea
• HS Code: 3506100090
• Production Capacity: 10000

Product Description

Product Description

 

Revok50 is medical device CE CLASS III Certificate in the form of Sterile Gel Intended for Intradermal Injections. Revok50® combines stabilized hyaluronic acid with a uniform double chain length of 2,200 kDa and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCl). Revok50® is an optimal formulation for fibroblastic stimulation of collagen formation and maintenance of the extracellular matrix.

 

Revok50 Benefits

 

Revok50 - Intensive Integral Biostimulation.

Revok50 stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it and  delays cell apoptosis and tissue aging. Revoke50 exerts an anti-inflammatory and repairing action on connective tissue and it has less susceptibility to endogenous hyaluronidase thanks to its high molecular weight, resulting in a longer duration of treatment effects.

• Due to high molecular weight, revok50 is less susceptible than endogenous hyaluronidase, resulting in a longer duration of therapy effects.
• By optimizing the metabolic events that take place there, it stabilizes the extracellular matrix's electrolytic equilibrium.
• This injectable HA is 2.5 times more concentrated than other products on the market. 
• It delays cell apoptosis and tissue ageing.
• Lastly, it exerts an anti-inflammatory and repairing action on the connective tissue.

 

Revok50 Composition

 

 

HYALURONIC ACID + AMINO ACIDS 

Revok50® contains 50 mg. of 2,200kDa hyaluronic acid. and amino acids (L-proline, L-hydroxyproline, glycine and L-lysine HCI). It is a concentration 2.5 times higher than other products on the market.

HYALURONIC ACID AND OUR SKIN 

The skin's native hyaluronic acid is mainly made up of chains similar to those in the Revok50® composition. Non-crosslinked hyaluronic acid rapidly undergoes enzymatic degradation and breaks down into larger chains. In Revok50® this process is much slower thanks to the use of 2,200 kDa hyaluronic acid chains, which produce hydrogen bonds in an electrochemical process that stabilize the structure (ionic bonds between chains).

 

Revok50 Therapeutic Uses

 

 

MESOTHERAPY: FACE, NECK, DECOLLETE, ARMS AND HANDS 

Injection protocol: 

• Superficial dermis injection - medium 

• 30G 4mm needle. 

• Multipuncture technique. Angle < 15º: 

               * Papule (recommended separation between papules 5 - 10 mm.) 

                * Backtrace 

• Injection volume 0.01 - 0.02 ml. per point. 

• Treatment interval: one monthly session for three months (three sessions). 

• Compatible with a mesotherapy gun, it stabilizes the electrolytic balance of the extracellular matrix with optimization of the biochemical reactions that take place in it.

 

DOUBLE CROWN LIFT (DCL TECHNIQUE) 

The Double Crown Lift (DCL) technique has been exclusively developed by THR Medical Products by Dr. JR Vázquez. 

The technique is based on anchoring the superficial facial retention ligaments and the lines of skin tension. 

Injection protocol: 

• Deep dermis injection 
• 30G needle (4 - 6 mm.) or 27/25G cannula 
• Papula point by point technique. 
• Injection angle >45º 
• Injection volume 0.1 ml. per point (one 2 ml syringe per session). 
• Treatment interval: one session per month for 3 months (three sessions). 
• A 2 ml Revok50® syringe is used in each session.

 

Revok50 Indications

 

 

Revok50 can treat skin dehydration 

Repair of injuries caused by environmental agents such as UV radiation and pollution. 

Connective tissue lesions such as stretch marks, scars and other dystrophies. 

Synergism with other aesthetic treatments such as fillers, lasers, microneedling. 

Fine and medium wrinkles

 

Clinically Proven

 

 

Previous

Next

 

 

 

 

 

 

 

 

 Remarss company covers an area of 35000 square meters,of which the purification workshop is 8000 square meters.
The company has independent research and development of Beijing university of more than 50 sets of advanced modern machinery and equipment, 
such as agnail cutting machine, automatic group installed, blister packing machine and so on.We also have more than 10 quality inspection personnel and 150 employees trained.
The annual production capacity of pdo thread and hyaluronic acid company is 5 million pieces.